New preprints, nonprofit research updates, and science releases on the type 1 diabetes cure, surfaced early and labeled honestly. Preprints are the earliest data: small studies, not yet peer reviewed, and exactly where breakthroughs first show up.
Preprints are not peer reviewed and early findings often change. This lane is for the earliest research signal, clearly labeled. It is information, not medical advice.
Living with type 1 diabetes (T1D) means managing the disease every day while navigating its complexities. That’s why dispelling common myths and misconceptions is so important. They can make life even harder for people living with T1D.  We’re always working to create greater awarenes…
Read the sourceGolf champion J.J. Spaun discusses his game and life with T1D with dedicated Breakthrough T1D supporter Moira McCarthy. The post Golf Champion J.J. Spaun: A Hero Who’s One of Us appeared first on Breakthrough T1D .
Read the sourceLearn more about GLP-1 therapies and SGLT inhibitors, and how drugs like Ozempic may one day be able to help people with type 1 diabetes. The post Could Drugs Like Ozempic also Benefit People with Type 1 Diabetes? appeared first on Breakthrough T1D .
Read the sourceSummer is officially in full swing, which means members of the type 1 diabetes (T1D) community across the country are heading out for days at the pool, beach, or a neighborhood barbecue (check out our summer guide for all your T1D tips!). But for the Tierney family in Sacramento, summer also means it’s time for [̷…
Read the sourceWhat’s Happening? In an exciting update for the type 1 diabetes (T1D) community, Tzield—the first disease-modifying therapy approved by the FDA to delay progression of stage 2 T1D—has now been approved by the FDA for use in stage 3 T1D. People aged 8-17 with stage 3 T1D will soon be able to get…
Read the sourceWhile it was once thought that neurogenesis is complete by birth, it is now apparent that the human brain continues to generate new neurons postnatally, at least into childhood. While much attention has been focused on postnatally-born neurons, their presumed progenitor - the postnatal neural stem cell (NSC) - remains…
Read the sourceHuman brain development proceeds on an unusually long timeline relative to other species, a feature that is thought to foster advanced cognitive abilities. Retinoic Acid Induced 1 (RAI1) gene encodes a nucleosome-binding protein haploinsufficient in Smith-Magenis Syndrome (SMS), a neurodevelopmental disorder character…
Read the sourceInferring early cell fate from single-cell RNA-sequencing data is essential for identifying cellular origins and fate plasticity in development and disease. However, existing methods often fail to exploit tree-structured lineage trajectories, limiting the accuracy and interpretability of fate mapping. Here we present …
Read the sourceBreakthrough T1D was on site in New Orleans, LA from June 5-8 for the American Diabetes Association’s (ADA) 86th Scientific Sessions. Check out all of our coverage below, including type 1 diabetes (T1D) advances across all our mission priority areas and several Breakthrough T1D-funded researchers and staff driving pro…
Read the sourceBreakthrough T1D is here to answer all of your questions about islet cell therapies, from the research lab to real-world treatments. The post Cell Therapy Clinical Trials: Breaking Down the Science appeared first on Breakthrough T1D .
Read the sourceADA’s 86th Scientific Sessions This event is one of the largest diabetes conferences in the world, bringing together over 11,000 attendees to share and learn about cutting-edge research and advancements toward cures. Each year, Breakthrough T1D-funded researchers highlight their work, demonstrating the progress …
Read the sourceNew data from a Breakthrough T1D–funded islet cell transplant trial shows all 12 participants are off external insulin using tegoprubart. The post All 12 Clinical Trial Participants Off External Insulin: New Data on Tegoprubart Continues to Impress appeared first on Breakthrough T1D .
Read the sourceADA’s 86th Scientific Sessions This event is one of the largest diabetes conferences in the world, bringing together over 11,000 attendees to share and learn about cutting-edge research and advancements toward cures. Each year, Breakthrough T1D-funded researchers highlight their work, demonstrating the progress …
Read the source